article thumbnail

Covid-19 vaccine success bolsters nanoparticle drug delivery research

Pharmaceutical Technology

If successful, such applications could be used for neurodegenerative conditions like Alzheimer’s disease. Libera Bio is using these nanocarriers , developed by the company’s cofounder MJ Alonso, PhD, professor, Department for Pharmacy and Pharmaceutical Technology, Universidade de Santiago de Compostela, to deliver antibodies.